Literature DB >> 19682606

The m.3243A>G mtDNA mutation is pathogenic in an in vitro model of the human blood brain barrier.

Mercy M Davidson1, Winsome F Walker, Evelyn Hernandez-Rosa.   

Abstract

MELAS is a common mitochondrial disease frequently associated with the m.3243A>G point mutation in the tRNA(Leu(UUR)) of mitochondrial DNA and characterized by stroke-like episodes with vasogenic edema and lactic acidosis. The pathogenic mechanism of stroke and brain edema is not known. Alterations in the blood brain barrier (BBB) caused by respiratory chain defects in the cortical microvessels could explain the pathogenesis. To test this hypothesis we developed a tissue culture model of the human BBB. The MELAS mutation was introduced into immortalized brain capillary endothelial cells and astrocytes. Respiratory chain activity and transendothelial electrical resistance, TEER was measured. Severe defects of respiratory chain complex I and IV activities, and a moderate deficiency of complex II activity in cells harboring the MELAS mutation were associated with low TEER, indicating that the integrity of the BBB was compromised. These data support our hypothesis that respiratory chain defects in the components of the BBB cause changes in permeability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682606      PMCID: PMC2783492          DOI: 10.1016/j.mito.2009.08.006

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  32 in total

1.  Long-term analysis of differentiation in human myoblasts repopulated with mitochondria harboring mtDNA mutations.

Authors:  C Sobreira; M P King; M M Davidson; H Park; Y Koga; A F Miranda
Journal:  Biochem Biophys Res Commun       Date:  1999-12-09       Impact factor: 3.575

2.  Serial diffusion-weighted imaging in MELAS.

Authors:  T Ohshita; M Oka; Y Imon; C Watanabe; S Katayama; S Yamaguchi; T Kajima; Y Mimori; S Nakamura
Journal:  Neuroradiology       Date:  2000-09       Impact factor: 2.804

3.  Mechanisms of glucose transport at the blood-brain barrier: an in vitro study.

Authors:  M S McAllister; L Krizanac-Bengez; F Macchia; R J Naftalin; K C Pedley; M R Mayberg; M Marroni; S Leaman; K A Stanness; D Janigro
Journal:  Brain Res       Date:  2001-06-15       Impact factor: 3.252

4.  A comparison of the induction of immortalized endothelial cell impermeability by astrocytes.

Authors:  K H Tan; M S Dobbie; R A Felix; M A Barrand; R D Hurst
Journal:  Neuroreport       Date:  2001-05-25       Impact factor: 1.837

5.  Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging.

Authors:  M Yoneda; M Maeda; H Kimura; A Fujii; K Katayama; M Kuriyama
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

Review 6.  Blood-brain barrier tight junction permeability and ischemic stroke.

Authors:  Karin E Sandoval; Ken A Witt
Journal:  Neurobiol Dis       Date:  2008-08-27       Impact factor: 5.996

7.  Enhanced oxidative damage in human cells harboring A3243G mutation of mitochondrial DNA: implication of oxidative stress in the pathogenesis of mitochondrial diabetes.

Authors:  C Y Pang; H C Lee; Y H Wei
Journal:  Diabetes Res Clin Pract       Date:  2001-12       Impact factor: 5.602

Review 8.  Mitochondria, oxygen free radicals, disease and ageing.

Authors:  S Raha; B H Robinson
Journal:  Trends Biochem Sci       Date:  2000-10       Impact factor: 13.807

9.  GSH transport in human cerebrovascular endothelial cells and human astrocytes: evidence for luminal localization of Na+-dependent GSH transport in HCEC.

Authors:  R Kannan; R Chakrabarti; D Tang; K J Kim; N Kaplowitz
Journal:  Brain Res       Date:  2000-01-10       Impact factor: 3.252

Review 10.  Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome.

Authors:  Douglas M Sproule; Petra Kaufmann
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more
  9 in total

1.  Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

Authors:  Valerie Desquiret-Dumas; Naig Gueguen; Magalie Barth; Arnaud Chevrollier; Saege Hancock; Douglas C Wallace; Patrizia Amati-Bonneau; Daniel Henrion; Dominique Bonneau; Pascal Reynier; Vincent Procaccio
Journal:  Biochim Biophys Acta       Date:  2012-01-28

2.  Metabolic myopathies.

Authors:  Salvatore DiMauro; Caterina Garone; Ali Naini
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

Review 3.  Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.

Authors:  Evan B Stubbs
Journal:  Exp Neurol       Date:  2020-06-17       Impact factor: 5.330

4.  Hepatic encephalopathy: An approach to its multiple pathophysiological features.

Authors:  Juan Carlos Perazzo; Silvina Tallis; Amalia Delfante; Pablo Andrés Souto; Abraham Lemberg; Francisco Xavier Eizayaga; Salvador Romay
Journal:  World J Hepatol       Date:  2012-03-27

5.  Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report and Critical Reappraisal of Treatment Options.

Authors:  Robert H Fryer; Jennifer M Bain; Darryl C De Vivo
Journal:  Pediatr Neurol       Date:  2015-12-19       Impact factor: 3.372

6.  A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features.

Authors:  Yu Hongo; Juntaro Kaneko; Hiroki Suga; Daisuke Ishima; Eiji Kitamura; Tsugio Akutsu; Yuya Onozawa; Naomi Kanazawa; Tomohide Goto; Kazutoshi Nishiyama; Takahiro Iizuka
Journal:  J Neurol       Date:  2019-03-19       Impact factor: 4.849

7.  Tumour necrosis factor α enhances CCL2 and ICAM-1 expression in peripheral nerve microvascular endoneurial endothelial cells.

Authors:  Kelly A Langert; Cynthia L Von Zee; Evan B Stubbs
Journal:  ASN Neuro       Date:  2013-02-06       Impact factor: 4.146

8.  Quantitative measurement of cerebral oxygen extraction fraction using MRI in patients with MELAS.

Authors:  Lei Yu; Sheng Xie; Jiangxi Xiao; Zhaoxia Wang; Xiaodong Zhang
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

9.  Microangiopathy in the cerebellum of patients with mitochondrial DNA disease.

Authors:  Nichola Z Lax; Ilse S Pienaar; Amy K Reeve; Philippa D Hepplewhite; Evelyn Jaros; Robert W Taylor; Raj N Kalaria; Doug M Turnbull
Journal:  Brain       Date:  2012-05-09       Impact factor: 13.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.